Alcaftadine-d3
| Product Name | Alcaftadine-d3 |
|---|---|
| Alternate Names | Alcaftadine Stable Isotopes, Stable Isotopes of Alcaftadine |
| CAT No. | CS-T-65068 |
| CAS No. | 1794775-80-6 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Alcaftadine |
| Smileys | O=CC1=CN=C2N1CCC3=CC=CC=C3/C2=C4CCN(C([2H])([2H])[2H])CC\4 |
| Canonical Smiles | CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1 |
| InchIKey | MWTBKTRZPHJQLH-FIBGUPNXSA-N |
| Inchl | InChI=1S/C19H21N3O/c1-21-9-6-15(7-10-21)18-17-5-3-2-4-14(17)8-11-22-16(13-23)12-20-19(18)22/h2-5,12-13H,6-11H2,1H3/i1D3 |
| IUPAC | 11-[1-(trideuteriomethyl)piperidin-4-ylidene]-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Alcaftadine-d3 is a synthetic compound that is used as a medication for the treatment of allergic conjunctivitis. It is a deuterated form of alcaftadine, which means that it contains three deuterium atoms instead of three hydrogen atoms. This modification makes it more stable and less likely to undergo metabolic breakdown in the body, resulting in a longer half-life and increased efficacy.
The mechanism of action of alcaftadine-d3 involves the inhibition of histamine H1 receptors in the eyes. Histamine is a chemical that is released during an allergic reaction and causes inflammation and itching. By blocking the histamine receptors, alcaftadine-d3 reduces the symptoms of allergic conjunctivitis, such as redness, swelling, and itching.
Alcaftadine-d3 is administered as an ophthalmic solution, which is instilled directly into the eyes. The usual recommended dose is one drop in each affected eye twice a day. It is important to follow the dosage instructions provided by a healthcare professional and not to exceed the recommended dose.
The safety and efficacy of alcaftadine-d3 have been evaluated in clinical trials. It is generally well-tolerated, with the most common adverse effects being mild burning or stinging sensation upon instillation. In rare cases, more serious adverse reactions may occur, such as eye pain, vision changes, or allergic reactions. If any adverse effects occur, it is important to seek medical attention promptly.
Get an Instant Quote
Related Compounds
Alcaftadine 3-Carboxylic Acid D3 |